BR112015024743A2 - composto de biarila substituída - Google Patents

composto de biarila substituída

Info

Publication number
BR112015024743A2
BR112015024743A2 BR112015024743A BR112015024743A BR112015024743A2 BR 112015024743 A2 BR112015024743 A2 BR 112015024743A2 BR 112015024743 A BR112015024743 A BR 112015024743A BR 112015024743 A BR112015024743 A BR 112015024743A BR 112015024743 A2 BR112015024743 A2 BR 112015024743A2
Authority
BR
Brazil
Prior art keywords
substituted biaryl
biaryl compound
compound
present
substituted
Prior art date
Application number
BR112015024743A
Other languages
English (en)
Inventor
Yoneda Kenji
Yamamoto Kiyoshi
Ito Koji
Shibakawa Nobuhiko
Iwase Noriaki
Ushiyama Shigeru
Katsube Tetsushi
Kanda Tomoko
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries filed Critical Ube Industries
Publication of BR112015024743A2 publication Critical patent/BR112015024743A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

resumo patente de invenção para: "composto de biarila substituída." a presente invenção fornece um composto de biarila substituída de fórmula geral (i) (em que, r1, w, r2, e z são como definidos nas reivindicações e descrição), ou um sal farmacologicamente aceitável do mesmo. o composto de acordo com a presente invenção tem um efeito de inibição excelente de proliferação de um fibroblasto pulmonar, e é, portanto, útil como um agente terapêutico e/ou um agente profilático para pneumonia intersticial e fibrose pulmonar.
BR112015024743A 2013-03-28 2014-03-28 composto de biarila substituída BR112015024743A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013069363 2013-03-28
JP2013228489 2013-11-01
PCT/JP2014/059301 WO2014157672A1 (ja) 2013-03-28 2014-03-28 置換ビアリール化合物

Publications (1)

Publication Number Publication Date
BR112015024743A2 true BR112015024743A2 (pt) 2017-07-18

Family

ID=51624629

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015024743A BR112015024743A2 (pt) 2013-03-28 2014-03-28 composto de biarila substituída

Country Status (15)

Country Link
US (1) US9676720B2 (pt)
EP (1) EP2980075A4 (pt)
JP (1) JPWO2014157672A1 (pt)
KR (1) KR20150135460A (pt)
CN (1) CN105308023A (pt)
AU (1) AU2014244926A1 (pt)
BR (1) BR112015024743A2 (pt)
CA (1) CA2908223A1 (pt)
HK (2) HK1219103A1 (pt)
MX (1) MX2015013848A (pt)
PH (1) PH12015502255A1 (pt)
RU (1) RU2015145989A (pt)
SG (1) SG11201507976YA (pt)
TW (1) TW201527282A (pt)
WO (1) WO2014157672A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10774072B2 (en) 2014-06-10 2020-09-15 Ube Industries, Ltd. Crystal of N-substituted sulfonamide compound
KR102374969B1 (ko) 2014-06-10 2022-03-16 우베 고산 가부시키가이샤 헤테로 방향족 술폰아미드 화합물의 제조 방법
CA2951784C (en) * 2014-06-10 2022-05-31 Ube Industries, Ltd. N-substituted sulfonamide compound and method for producing same
JP2017206443A (ja) * 2014-09-26 2017-11-24 宇部興産株式会社 置換ビアリール化合物及び他の医薬の組み合わせ
JP2017206445A (ja) * 2014-09-26 2017-11-24 宇部興産株式会社 呼吸器疾患の治療及び／又は予防のための医薬組成物
WO2017161555A1 (zh) * 2016-03-25 2017-09-28 沈阳三生制药有限责任公司 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US20020063763A1 (en) 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
JP2003528107A (ja) 2000-03-22 2003-09-24 メルク フロスト カナダ アンド カンパニー Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類
RU2306309C2 (ru) 2002-03-05 2007-09-20 Оно Фармасьютикал Ко., Лтд. Производное 8-азапростагландина, фармацевтическая композиция, агент для профилактики заболеваний
MXPA05009398A (es) 2003-03-04 2005-12-05 Pfizer Prod Inc Uso de agonistas selectivos del receptor ep2 en tratamiento medico.
EP1723132A1 (en) 2004-02-12 2006-11-22 Asterand Uk Limited Ep2 receptor agonists
US7858650B2 (en) 2004-10-22 2010-12-28 Ono Pharmaceutical Co., Ltd. Medicinal composition for inhalation
ATE474839T1 (de) 2005-01-14 2010-08-15 Hoffmann La Roche Thiazol-4-carboxamid-derivate als mglur5- antagonisten
WO2007017687A2 (en) 2005-08-09 2007-02-15 Asterand Uk Limited Ep2 receptor agonists
CN101495452B (zh) * 2006-07-28 2012-04-25 辉瑞产品公司 Ep2激动剂
EA200970067A1 (ru) 2006-07-28 2009-08-28 Пфайзер Продактс Инк. Агонисты ep2
WO2008065500A2 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Heteroaryl amides as type i glycine transport inhibitors
EP2078020A4 (en) 2007-04-10 2011-10-19 Sgx Pharmaceuticals Inc HETEROCYCLIC MODULATORS WITH FUSED CYCLES FOR KINASES
ES2718813T3 (es) * 2008-03-12 2019-07-04 Ube Industries Compuesto de ácido piridilaminoacético
DK2415763T3 (en) 2009-03-30 2016-03-07 Ube Industries A pharmaceutical composition for the treatment or prevention of glaucoma
EP2476678A4 (en) 2009-09-11 2013-02-20 Ube Industries SUBSTITUTED CARBONYL COMPOUNDS
WO2011030864A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 アニリン化合物
WO2011030865A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 置換ベンジル化合物
WO2011030872A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 スルホンアミド化合物
WO2011030873A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 ベンジル化合物
WO2011030871A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 Ｎ－置換ヘテロアリール化合物
AU2010336248A1 (en) 2009-12-25 2012-08-02 Ube Industries, Ltd. Aminopyridine compound
TW201542525A (zh) * 2013-09-02 2015-11-16 Ube Industries 肺疾患的治療及／或預防用的醫藥組成物

Also Published As

Publication number Publication date
RU2015145989A (ru) 2017-05-16
WO2014157672A1 (ja) 2014-10-02
PH12015502255A1 (en) 2016-02-01
US20160060221A1 (en) 2016-03-03
MX2015013848A (es) 2016-03-01
TW201527282A (zh) 2015-07-16
AU2014244926A1 (en) 2015-11-12
JPWO2014157672A1 (ja) 2017-02-16
HK1220457A1 (zh) 2017-05-05
KR20150135460A (ko) 2015-12-02
CA2908223A1 (en) 2014-10-02
US9676720B2 (en) 2017-06-13
CN105308023A (zh) 2016-02-03
EP2980075A1 (en) 2016-02-03
SG11201507976YA (en) 2015-10-29
HK1219103A1 (zh) 2017-03-24
EP2980075A4 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
CY1123637T1 (el) Αναστολεις μεθυλοτρανσφερασης αργινινης και χρησεις αυτων
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
BR112015024743A2 (pt) composto de biarila substituída
PH12018502125A1 (en) Bipyrazole derivatives as jak inhibitors
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BR112014029139A8 (pt) compostos inibidores da atividade de catecol o-metiltransferase
MX2016002794A (es) Compuestos antiproliferativos.
MX2015010125A (es) Derivados de piridazinona-amidas.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
BR112015016395A2 (pt) pirazóis 3-substituídos e uso como inibidores de dlk
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
MX2016004742A (es) Derivados de piridil cetona, metodo de preparacion de los mismos, y la aplicacion farmaceutica de los mismos.
UA118666C2 (uk) Похідні піразолу
BR112015019276A2 (pt) compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
GEP20186885B (en) Novel compounds
CR20150432A (es) Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
MY173573A (en) Pyridin-4-yl derivatives
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
MX2015012318A (es) Formas de estado solido de un derivado de quinazolina y su uso como un inhibidor de braf.
MX2015013151A (es) Métodos de tratamiento de disquinesia y trastornos relacionados.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2507 DE 22-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI